Skip to content

The predictive value of multimodal intergration system in predicting axillary lymph node response after neoadjuvant chemotherapy for breast cancer

The predictive value of multimodal intergration system in predicting axillary lymph node response after neoadjuvant chemotherapy for breast cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077197
Enrollment
Unknown
Registered
2023-11-01
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Sponsors

Yantai Yuhuangding Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.the patients were confirmed by biopsy as invasive breast cancer with ipsilateral ALN metastases; 2.the patients should have adequate hematologic, liver, and renal function at enrollment; 3. the enrolled patients were planned to receive a standard NAC treatment, followed by ALND; patients who have been undergoing or have completed the standard NAC waiting for the surgery will also deemed eligible; 4.axillary lymph node pathological NAC response (pCR or non-pCR) was confirmed; 5.MRI and whole slide imaging (WSI) of biopsy were available; both MRI and biopsy were conducted within 2 weeks before NAC; 6.no other tumor occurred during NAC and operation.

Exclusion criteria

Exclusion criteria: 1.a history of chemoradiation therapy, surgery, or malignancy; 2.the patients received non-standard treatment or did not complete the NAC regimen; 3.no surgery was performed or the results of postoperative pathology were incomplete; 4.lack of clinical information, MRI images, and WSI for analysis requirements; 5.insufficient quality of MRI images or WSI; 6.patients with multifocal, bilateral, or occult breast cancer.

Design outcomes

Primary

MeasureTime frame
Area under receiver operating characteristic curve;

Secondary

MeasureTime frame
Sensitivity;Specificity;Accuracy;

Countries

China

Contacts

Public ContactNing Mao

Yantai Yuhuangding Hospital

maoning@pku.edu.cn+86 131 0535 1972

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026